http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32137419

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
endingPage 98
issn 1466-0822
issueIdentifier 2
pageRange 84-98
publicationName Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
startingPage 84
bibliographicCitation Leigh PN, Swash M, Iwasaki Y, Ludolph A, Meininger V, Miller RG, Mitsumoto H, Shaw P, Tashiro K, Van Den Berg L. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Jun;5(2):84–98. doi: 10.1080/14660820410020187. PMID: 15204010.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8925-2567
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49c0d73feeb003d842f7e09530e79368
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0adfc7984f2bc219ea4d138dbdb6d56b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2af1e43bfc979683a51349dae0c990e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f283922b6012bb01edd4382d3d82feb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf62479d2f23619e577235f474ceebbc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b7c9667579123abf15fe16cf980f1e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b71b2b884d9baab3aa929b76c4fa7f79
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8717-8914
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80fb0e582723c2e80f1baccb1b75fbd9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bce3fd22121a52d29970f1afa50da71
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_777db9332f6d1fcb5cd245a52924d6e1
date 200401
identifier https://pubmed.ncbi.nlm.nih.gov/15204010
https://doi.org/10.1080/14660820410020187
isPartOf https://portal.issn.org/resource/ISSN/1466-0822
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22467
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial
discusses http://id.nlm.nih.gov/mesh/M0029347
http://id.nlm.nih.gov/mesh/M0287998
http://id.nlm.nih.gov/mesh/M0015643
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000690Q000503
http://id.nlm.nih.gov/mesh/D000690Q000628
http://id.nlm.nih.gov/mesh/D000690Q000175
http://id.nlm.nih.gov/mesh/D002986Q000379
http://id.nlm.nih.gov/mesh/D000690Q000453
http://id.nlm.nih.gov/mesh/D003245
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010082Q000627
http://id.nlm.nih.gov/mesh/D002986Q000706
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D019782Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6419718

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127895450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129040233

Total number of triples: 47.